Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer
Authors:
- Jürgen DingerJDJürgen Dinger
- Kristina BardenheuerKBKristina Bardenheuer
- Thai Do MinhTMThai Do Minh
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 83 (3) , 211-217
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Explaining risk. A guide for health professionalsMaturitas, 2009
- A case‐control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as wellInternational Journal of Cancer, 2009
- Breast cancer tumor growth estimated through mammography screening dataBreast Cancer Research, 2008
- The use and misuse of matching in case-control studies: the example of polycystic ovary syndromeFertility and Sterility, 2007
- Compared to what? Finding controls for case-control studiesThe Lancet, 2005
- Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancerContraception, 2004
- Epidemiology of breast cancer – selected highlightsThe Breast, 2003
- On the growth rates of human malignant tumors: Implications for medical decision makingJournal of Surgical Oncology, 1997
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996
- Levonorgestrel-Releasing Intrauterine DeviceAnnals of Medicine, 1990